Chesapeake Endocrinology

04/21/2026

Can I tell you the number one reason women don't get great menopause care?

Time. Or the lack of it.

When you're in a traditional insurance-based practice, your doctor might have 10–15 minutes with you. Maybe less. Menopause is complicated. Hormones are complicated. Your history, your symptoms, your preferences, your fears — none of that fits into a 10-minute appointment.

That's one of the biggest reasons I built Chesapeake Endocrinology as a direct care practice.

No insurance middlemen. No rushed visits. No "we'll address that at your next appointment." Just actual time to talk through what's happening in your body and what your options really are — from a board-certified endocrinologist who is also a certified menopause practitioner through The Menopause Society.

Menopause care done right isn't a one-size-fits-all prescription. It's:

✅ Understanding your full symptom picture
✅ Reviewing your personal and family health history
✅ Discussing ALL your options — hormonal and non-hormonal
✅ Finding the right formulation, dose, and delivery method for YOU
✅ Following up to make sure it's actually working

You've spent years taking care of everyone else. This chapter is about taking care of you. 💛

Curious about what direct care menopause support looks like? Visit us at cendomd.com or drop a question below.

04/14/2026

This is genuinely big news and I don't think it's getting enough attention. 📣

In November 2025, the FDA removed the black box warning from hormone therapy labeling. If you've ever been scared away from HRT because of a warning label — this is for you.

For decades, that black box warning listed scary-sounding risks — cardiovascular disease, breast cancer, dementia — risks that were largely extrapolated from a single flawed study (the WHI) using older hormone formulations in older women. The science has moved way beyond that, and the FDA finally caught up.

The updated labeling now reflects literature supporting that hormone therapy may actually be associated with reduced risk of:

⭐ All-cause mortality
⭐ Heart attack
⭐ Fractures
⭐ Cognitive decline
⭐ Alzheimer's disease

The endometrial cancer warning for estrogen-alone products remains (which is appropriate — that's why we always pair it with progesterone in women with a uterus).

This doesn't mean hormone therapy is right for everyone. Timing matters. Your health history matters. But it does mean that millions of women who were told "no" based on outdated label language deserve a fresh conversation with an informed provider.

If you've been putting off asking about menopause treatment because you were worried about the risks — I'd love to talk. That's exactly what we're here for.

🔗 menopause.org has a free provider search if you're looking for certified menopause specialists near you.



www.cendomd.com

Chesapeake Endocrinology is providing quality of care that is accessible to patients, in a safe and judgment free setting

04/11/2026

Women are suffering through menopause symptoms — hot flashes, brain fog, sleep issues, mood changes, low libido — and they are desperate for help. And unfortunately, some clinics and med spas are taking advantage of that desperation.

One of the biggest ones I see? Pellet therapy being pushed as a first-line hormone treatment.

Here's what you need to know:

🚫 Pellet therapy (small hormone implants inserted under the skin) is NOT considered standard care for menopause by The Menopause Society. Neither are hormone injections for symptom management.

Standard, FDA-approved options — patches, pills, gels, creams, sprays, vaginal rings — have decades of safety data behind them. They're adjustable. They're reversible. And they work.

Pellets, on the other hand, can't be removed once they're in. Hormone levels can spike unpredictably. The Menopause Society has specifically flagged compounded hormones (which pellets almost always are) as a potential safety concern because they're largely unregulated and delivered in untested forms.

Pellet or injectable therapy might be appropriate — but only if you've already tried and failed standard delivery methods. That's a very different conversation than being offered pellets as your very first option at a cash-pay medspa.

✅ Here's my ask: If you're looking for menopause care, please find a certified, knowledgeable provider first. The Menopause Society has a free provider search at menopause.org where you can find physicians and other practitioners who are certified in menopause care. Look for the MSCP (Menopause Society Certified Practitioner) credential.

You deserve evidence-based care — not a trendy upsell. 💛


www.cendomd.com

Chesapeake Endocrinology is providing quality of care that is accessible to patients, in a safe and judgment free setting

04/06/2026

This one hits close to home as an endocrinologist — and as a parent.

Two brand-new studies published in the last two months in the Journal of the Endocrine Society are raising serious concerns about PFAS — the so-called "forever chemicals" found in nonstick cookware, food packaging, water-resistant clothing, and the drinking water of an estimated 200 million Americans.

Here's what the new research found:

🦴 Study 1 — Kids' Bones:
Kids with higher PFAS levels had weaker bones by age 12. Girls were hit harder. We're talking a potentially 10–30% higher chance of fractures — and that's before we even get to what it could mean for osteoporosis down the road.

🦋 Study 2 — Thyroid Tissue:
A separate study out of Vanderbilt showed PFAS literally changes the structure of thyroid tissue and messes with thyroid hormone levels. Your thyroid runs your metabolism, your energy, your mood — basically everything.

As someone who spends all day thinking about hormones, this isn't shocking to me — but it IS a big deal. These chemicals don't leave your body. They build up over time. And they're interfering with the very systems that keep us healthy.

✅ What you can do right now:
→ Filter your drinking water (look for NSF-certified filters; reverse osmosis is most effective)
→ Swap nonstick cookware for ceramic, cast iron, or stainless steel
→ Limit fast food wrappers, pizza boxes, and microwave popcorn bags — common PFAS sources
→ Check whether your local water utility tests for PFAS (many post results publicly)

Small changes add up. Your hormones will thank you. 💛

Questions about your hormone health? We're here. 👇

04/02/2026

📌 For anyone who cares about diabetes care and medication access — this is worth knowing about.

The Endocrine Society recently endorsed the INSULIN Act, a rare bipartisan bill introduced in the U.S. Senate this month. Here's what it would do:

🔹 Cap out-of-pocket insulin costs at $35/month for people on private insurance
🔹 Extend the $35 cap that currently exists only for Medicare beneficiaries
🔹 Create a program to provide insulin access to people who are uninsured

Right now, that $35 cap only covers Medicare. Millions of Americans with private insurance — or no insurance at all — can still face enormous insulin costs. This bill would change that.

For context: insulin is not a new or experimental drug. It's been essential to survival for people with Type 1 diabetes for over 100 years. The fact that affordability is still a barrier in 2026 is something the medical community continues to push back on.

The Endocrine Society, which represents over 18,000 hormone health specialists worldwide, called this legislation a critical step toward protecting access to a life-saving medication.

This is the kind of policy change that directly affects real patients. Share if you think affordable insulin access matters. ❤️

04/02/2026

🚨 Big news in obesity medicine!
The FDA just approved Foundayo™ (orforglipron) — a once-daily pill for weight loss that you can take any time of day, with no food or water restrictions. No injections. No scheduling around meals. Just a simple daily pill.
In clinical trials, patients lost an average of 25 lbs over 72 weeks — with even greater results at the highest dose.

💊 What will it cost?
Commercial insurance: as little as $25/month with the Foundayo savings card
Self-pay: starting at $149/month (lowest dose)
Medicare Part D: $50/month expected beginning July 1, 2026

If you've been waiting for an oral option to manage your weight, this may be the moment.

www.cendomd.com

Chesapeake Endocrinology is providing quality of care that is accessible to patients, in a safe and judgment free setting

03/31/2026

🩺 Not All Hormone Therapy Is the Same — Here's What the Research Says

If you've ever looked into menopause hormone therapy (HRT), you've probably heard that it can raise breast cancer risk. But here's something important that often gets left out of that conversation: the type of hormones used makes a big difference.

The large Women's Health Initiative (WHI) study — the one that alarmed many women and doctors back in the early 2000s — used a synthetic hormone called MPA (medroxyprogesterone acetate). That study did find a higher breast cancer risk. But in women who took estrogen alone (no MPA), breast cancer risk actually went *down*. That tells us the synthetic progestin was the main problem, not estrogen itself.

So what about "natural" progesterone? 🌿

Multiple large studies from France and the UK have found that micronized progesterone — a form of progesterone that's chemically identical to what your body makes — does NOT appear to carry the same elevated breast cancer risk as MPA and other synthetic versions. One review combining data from nearly 87,000 women found a 33% lower risk compared to synthetic progestins.

03/26/2026

🔬 This is one of the most exciting — and underreported — areas of obesity medicine right now.

We already know that obesity is linked to over a dozen different cancers. What researchers are now actively studying is whether GLP-1 receptor agonists and their extended family of dual and triple agonists — which produce substantial, sustained weight loss — might also significantly reduce cancer risk with long-term use.

We don't have definitive answers yet. But the science is moving fast, and the early signals are genuinely promising.

And here's the piece that ties it all together for me: effective obesity care still requires a comprehensive strategy — nutrition, physical activity, behavioral support, pharmacotherapy when appropriate, and in some cases surgery. GLP-1s are a powerful piece of the puzzle. They're not the whole puzzle.

As someone board certified in both obesity medicine and lifestyle medicine, this is exactly the kind of integrated thinking I bring to every patient.

The goal isn't just a lower number on the scale. It's a longer, healthier life. 💙

📍 Chesapeake Endocrinology | Crofton, MD |
www.cendomd.com

03/23/2026

💊 The obesity treatment landscape is changing fast — and I want to make sure my patients understand what's actually coming.
A new oral semaglutide formulation for weight loss was approved in late 2025 and launched in early 2026, using specialized absorption technology that protects the peptide from stomach acid. And just last week, another daily obesity pill called aleniglipron showed patients lost about 16% of their body weight relative to placebo after 44 weeks in a Phase 2 trial — positioning it as a future competitor in the oral medication space.

More options are genuinely great news for patients. But more options also means more complexity — and more potential for people to start something without real medical guidance.
Here's my honest take: the pill form doesn't change the fundamental truth about obesity treatment. Obesity is a chronic relapsing condition that cannot be cured with a drug alone. We need to invest in lifestyle support while people are on medication, to ensure they don't experience rapid weight regain if they ever come off it.

Medication is a powerful tool. But it works best alongside a plan, a doctor who knows your history, and ongoing support.

That's exactly what we do here. 🩺

www.cendomd.com

Chesapeake Endocrinology is providing quality of care that is accessible to patients, in a safe and judgment free setting

03/22/2026

As an endocrinologist, I care for patients with Type 1 diabetes who are at serious risk for heart disease and kidney failure. There is a class of medications — GLP-1s (think Ozempic, Wegovy, Mounjaro) — that could protect their hearts and kidneys, reduce their insulin needs, and genuinely change their outcomes. I see it work every day in my Type 2 patients.

But for Type 1 patients, insurance keeps saying no. And every “no” means my team and I spend hours writing appeals and prior authorization letters instead of caring for patients — while my patients wait and their risk grows.

So I decided to do something. I am filing a formal petition with the FDA to get this medication approved for Type 1 diabetes — and I need enough signatures to make it count.

You do not have to be a doctor to sign. You just have to care.

✍️ Sign here ⬇️
https://docs.google.com/forms/d/e/1FAIpQLSeJ9ywCOdTJ52UaP-jVr7JUjSgvGo_kQMY8wh0IEagCaJCioA/viewform?usp=dialog

Please share this as widely as you can — with friends, family, coworkers, anyone. Every signature and every share brings us closer to getting this in front of the FDA. This population has waited long enough.

— Dr. Onala Telford

We, the undersigned physicians, healthcare providers, and members of the public, support and co-sign this FDA Citizen Petition requesting approval and/or an expedited regulatory pathway for GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide, tirzepatide) as adjunctive therapy in adults w...

03/21/2026

Here's something that doesn't get talked about enough — and as an endocrinologist, I see it constantly in my practice.
A significant number of patients on levothyroxine for hypothyroidism still don't feel well — even when their doctor tells them their labs are "normal." Research published in the Journal of Clinical Endocrinology & Metabolism helps explain why: nearly half of hypothyroid patients find the fasting requirement for levothyroxine burdensome, and a third admit they don't take it consistently. That alone can quietly throw off your thyroid levels without you realizing it.

But inconsistent dosing isn't the only issue. The American Thyroid Association acknowledges that a meaningful portion of patients on standard levothyroxine therapy report they still don't feel like themselves — even with a TSH in the "normal" range. Fatigue, weight struggles, brain fog, low mood. Sound familiar?
The science suggests that some patients may do better with adjusted dosing strategies or the addition of T3 to their regimen. These aren't fringe ideas — they're recognized areas of ongoing thyroid research.

If you've been on thyroid medication for years and still don't feel right, that's not in your head. And it's absolutely worth a deeper conversation with someone who specializes in this.

That's what I'm here for.

Chesapeake Endocrinology is providing quality of care that is accessible to patients, in a safe and judgment free setting

03/20/2026

👁️ If you or someone you love has Graves' disease, this is news worth paying attention to.

The FDA recently accepted and granted Priority Review to veligrotug, a new treatment for thyroid eye disease — a serious and often overlooked complication of Graves' disease. In clinical trials, 70% of patients who received it showed significant improvement in eye protrusion at 15 weeks, with a target FDA decision date of June 30, 2026.

Thyroid eye disease can be one of the most distressing aspects of Graves' — affecting vision, appearance, and quality of life in ways that thyroid treatment alone doesn't address. For years, options were limited. That's starting to change.

As an endocrinologist who manages Graves' disease and hyperthyroidism, I think it's important for my patients to know what's on the horizon — not just what's available today.

If you have Graves' disease and are experiencing eye symptoms, please don't brush them off. Early evaluation matters.

📩 Questions? Reach out at www.cendomd.com

Chesapeake Endocrinology is providing quality of care that is accessible to patients, in a safe and judgment free setting